Simon Farrell (CIK 1965585) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-12). Recent activity: Buy TRVI (17,500 shares), Buy TRVI (63,813 shares), Buy TRVI (31,250 shares), Sell TRVI (76,963 shares), Sell TRVI (4,350 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-12 | Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | Buy | 17,500 | $56,175 |
| 2025-03-12 | Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | Buy | 63,813 | $249,509 |
| 2025-03-12 | Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | Buy | 31,250 | $15,938 |
| 2025-03-12 | Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | Sell | 76,963 | $517,961 |
| 2025-03-12 | Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | Sell | 4,350 | $31,102 |
Source: SEC Form 4 filings · as of 2025-03-12